Davis Hl
- Otorhinolaryngology top 2%
-
- Cancer Treatment and Pharmacology 2
-
- Sarcoma Diagnosis and Treatment 1
- Advanced Breast Cancer Therapies 1
-
- Radiomics and Machine Learning in Medical Imaging 1
-
- Cancer Research and Treatments 1
-
- Neuroendocrine Tumor Research Advances 1
-
- Health Systems, Economic Evaluations, Quality of Life 1
- Economic and Financial Impacts of Cancer 1
- Co-authors
- Ansfield FjGuillermo RamírezHalvor VermundGerald E. MetterJudith B. KlotzTheodor B. GrageFletcher WsFranco M. Muggia
- Journals
- American Journal of Roentgenology (1 paper)PubMed (7 papers)Medical Entomology and Zoology (1 paper)
- Partner nations
- United States
In The Last Decade
Davis Hl
8 papers receiving 224 citations
Peers
Comparison fields: 5 of 38
- Otorhinolaryngology 153
- Oncology 136
- Pulmonary and Respiratory Medicine 92
- Surgery 108
- Pathology and Forensic Medicine 22
Countries citing papers authored by Davis Hl
This map shows the geographic impact of Davis Hl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davis Hl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davis Hl more than expected).
Fields of papers citing papers by Davis Hl
This network shows the impact of papers produced by Davis Hl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davis Hl. The network helps show where Davis Hl may publish in the future.
Co-authorship network
The 10 scholars most cited alongside Davis Hl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Comparisons of Cooperative Group evaluation criteria for multiple-drug therapy for breast cancer. | 1980 | 3 |
| 2 | Current cooperative clinical trials in the non-Hodgkin's lymphomas. | 1977 | 1 |
| 3 | Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.? | 1976 | 6 |
| 4 | 1976 | 199 | |
| 5 | Combined intra-arterial chemotherapy and radiotherapy with special reference to osteogenic sarcoma. | 1974 | 1 |
| 6 | Further clinical studies of 5-fluorouracil (5-FU; NSC-19893) given by the multiple daily dose method in disseminated breast cancer. | 1973 | 4 |
| 7 | Five-drug therapy for advanced breast cancer: a phase I study. | 1971 | 14 |
| 8 | Low doses of vincristine (NSC-67574) for malignant disease. | 1969 | 10 |
| 9 | Breast carcinoma metastatic to the stomach | 1968 | 7 |
About Davis Hl
Davis Hl is a scholar working on Otorhinolaryngology, Oncology, Statistics and Probability, Biotechnology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 245 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Advanced Breast Cancer Therapies (1 paper), Cancer Research and Treatments (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Economic and Financial Impacts of Cancer (1 paper). The work is most often cited by research in Otorhinolaryngology (153 citations), Oncology (136 citations), Pulmonary and Respiratory Medicine (92 citations), Surgery (108 citations) and Pathology and Forensic Medicine (22 citations). Davis Hl has collaborated with scholars based in United States. Frequent co-authors include Ansfield Fj, Guillermo Ramírez, Halvor Vermund, Guillermo Ramírez, Gerald E. Metter, Judith B. Klotz, Theodor B. Grage, Fletcher Ws, Franco M. Muggia and Marcel Rozencweig. Their work appears in journals such as American Journal of Roentgenology, PubMed and Medical Entomology and Zoology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.